The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Importance of clinical decision making in precision oncology: Discordance in recommendation between next generation sequencing test vendor and molecular tumour board in India.
 
Bhawna Sirohi
No Relationships to Disclose
 
Sissmol Davis
No Relationships to Disclose
 
Anu R I
No Relationships to Disclose
 
Moushumi Suryavanshi
No Relationships to Disclose
 
Shaheenah S. Dawood
Honoraria - Abbvie; AstraZeneca; biocon; Bristol-Myers Squibb; Caris Life Sciences; Celgene; Janssen-Cilag; MSD; Novartis; Pfizer; Roche
Consulting or Advisory Role - MSD Oncology
Speakers' Bureau - AstraZeneca; Pfizer; Roche/Genentech
Research Funding - MSD Oncology (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; MSD; Pfizer; Roche
 
Pankaj Kumar Panda
Employment - Apollo Proton Cancer Centre, Apollo Hospitals Enterprise Limited
Travel, Accommodations, Expenses - Reliance Life Sciences
 
Shona Milon Nag
No Relationships to Disclose
 
Arunangshu Das
No Relationships to Disclose
 
Nitesh Rohatgi
Honoraria - Guardant Health AMEA; Lilly; Roche India
Consulting or Advisory Role - Guardant Health AMEA
 
Sanjay Popat
Honoraria - Amgen; AstraZeneca; Bayer; BeiGene; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo; EQRx; GlaxoSmithKline; Guardant Health; Incyte; Janssen; Lilly; Merck KGaA; MSD; Novartis; Pfizer; Roche; Sanofi; Seagen; Takeda; Turning Point Therapeutics
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; BeiGene; Blueprint Medicines; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo; EQRx; GlaxoSmithKline; Guardant Health; Incyte; Janssen; Lilly; Merck KGaA; MSD; Novartis; Pfizer; Pfizer; Roche; Sanofi; Seagen; Takeda; Turning Point Therapeutics
Research Funding - Amgen (Inst); ARIAD (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Clovis Oncology (Inst); Daiichi Sankyo (Inst); Epizyme (Inst); GlaxoSmithKline (Inst); Guardant Health (Inst); Janssen (Inst); Lilly (Inst); Mirati Therapeutics; MSD (Inst); Novartis (Inst); Roche (Inst); Takeda (Inst); Trizell; Turning Point Therapeutics (Inst)
Expert Testimony - Merck KGaA; Roche
 
Riyaz N.H. Shah
Honoraria - AstraZeneca; Bayer; BeiGene; Boehringer Ingelheim; Bristol-Myers Squibb; EQRx; Guardant Health; Lilly; MSD; Novartis; Pfizer; Roche; Sanofi; Takeda
Consulting or Advisory Role - AstraZeneca; Bayer; BeiGene; Boehringer Ingelheim; Bristol-Myers Squibb; EQRx; Guardant Health; Lilly; MSD; Novartis; Pfizer; Roche; Sanofi; Takeda
Speakers' Bureau - AstraZeneca; Bayer; BeiGene; Boehringer Ingelheim; Bristol-Myers Squibb; EQRx; Guardant Health; Lilly; MSD; Novartis; Pfizer; Roche; Sanofi; Takeda
Research Funding - AstraZeneca (Inst); Bayer (Inst); BeiGene (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); EQRx (Inst); Guardant Health (Inst); Lilly (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bayer; BeiGene; Boehringer Ingelheim; Bristol-Myers Squibb; EQRx; Guardant Health; Lilly; MSD; Novartis; Pfizer; Roche; Sanofi; Takeda
(OPTIONAL) Uncompensated Relationships - ALK; British Thoracic Oncology Group; EGFR Positive UK; Roy Castle Lung Cancer Foundation
 
Cherian Thampy
No Relationships to Disclose
 
Aparna Raj Parikh
Consulting or Advisory Role - Abbvie; Bayer; Biofidelity; Checkmate Pharmaceuticals; CVS; Delcath Systems; Delcath Systems; Foundation Medicine; Genconn Biotech; Genconn Biotech; Guardant Health; Illumina; Inivata; Lilly; Natera; Pfizer; Roche/Genentech; SAGA Diagnostics; Scarce; Seagen; Taiho Oncology; UpToDate; Value Analytics Labs; xCures; xCures
Research Funding - Array BioPharma (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Erasca, Inc; Genentech (Inst); Guardant Health (Inst); Lilly (Inst); Mirati Therapeutics (Inst); Novartis Pharmaceuticals UK Ltd. (Inst); Plexxikon (Inst); PMV Pharma; PureTech (Inst)
Other Relationship - C2i genomics; Parithera; Xact Robotics
 
Siddhartha Yadav
Research Funding - REPARE Therapeutics (Inst)
 
Prashant Mehta
No Relationships to Disclose
 
Randeep Singh
Consulting or Advisory Role - AstraZeneca; MedGenome; Pfizer; Roche
 
Deborah Mukherji
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Janssen; Merck; Novartis; Pfizer; Roche
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; MSD Oncology; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Merck Serono (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Amgen; Merck Serono
 
Ramila Shilpakar
No Relationships to Disclose
 
Sujith Kumar Mullapally
No Relationships to Disclose
 
Aju Mathew
No Relationships to Disclose